Clinical Trial Update: A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of long-acting injectable risperidone and oral risperidone tablets in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Risperdal (risperidone)
• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED